Apeptico Forschung und Entwicklung's Series C Round

Apeptico Forschung und Entwicklung raised a round of funding on May 17, 2012. Investors include BioScience Ventures Group.

Apeptico Forschung und Entwicklung is a biotechnology company developing peptide-based products targeting chronic and life-threatening diseases. The peptide molecules correspond to validated, pharmaco…

Articles about Apeptico Forschung und Entwicklung's Series C Round: